Clicky

Intellia Therapeutics Inc(38I) News

Date Title
Apr 4 Intellia doses first subject in trial of nex-z for hereditary ATTRv-PN
Apr 3 IO360 Summit: Improving CAR-T cell therapy manufacture and accessibility
Apr 3 Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2 Phase 3 Study of Nexiguran Ziclumeran (nex-z), a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with Polyneuropathy
Apr 1 Is Intellia Therapeutics, Inc. (NTLA) the Best Gene-Editing Stock to Buy?
Apr 1 Biotech stocks slide as Marks resignation seen being negative for sector
Mar 31 Intellia Focuses on Pipeline Development Amid Stiff Competition
Mar 1 Intellia Therapeutics, Inc. (NASDAQ:NTLA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Feb 28 NTLA's Q4 Loss Narrower Than Estimates, Revenues Increase Y/Y
Feb 28 Intellia Therapeutics Full Year 2024 Earnings: Beats Expectations
Feb 28 Intellia Therapeutics Inc (NTLA) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...
Feb 28 Q4 2024 Intellia Therapeutics Inc Earnings Call
Feb 27 Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates
Feb 27 Intellia Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Company Progress
Feb 25 Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Feb 14 Intellia Therapeutics (NTLA): Among The Small–Cap Stocks Insiders Are Selling Recently
Feb 14 Does Intellia Therapeutics (NTLA) Have the Potential to Rally 422.41% as Wall Street Analysts Expect?
Dec 30 Why Is Intellia Therapeutics, Inc. (NTLA) Among the Top CRISPR Stocks to Invest In?
Oct 17 Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Oct 17 This Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street
Oct 16 Is Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds?